FGF21 also indirectly suppresses recruitment of CD4+ Th17 cells and secretion of IL-17 in a choline-deficient, high-fat diet model of NASH, by enhancing adiponectin release from adipose tissue (128). Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.